Products
Applications
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Products
System
Panels
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Products
System
Panels
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Liquid Biopsy
Search All publications
How recent?
Search
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis
Polymorphisms in donor and recipient p2x7 receptor predict patient outcome in allogeneic stem cell transplantation
A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection
Circulating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types
Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
Response: Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance …
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
Impact of blood collection tubes on CTC-, ctDNA-and miRNA recoveries in malignant melanoma patients
Monitoring advanced non-small cell lung cancer (NSCLC) through plasma genotyping during systemic treatment: KRAS-mutated (m) cohort results.
«
...
2
3
4
5
6
...
»